Part fund, part accelerator, Contrary Capital invests in student entrepreneurs

First Round Capital has both the Dorm Room Fund and the Graduate Fund. General Catalyst has Rough Draft Ventures. And Prototype Capital and a few other micro-funds focus on investing in student founders, but overall, there’s a shortage of capital set aside for entrepreneurs still making their way through school. Contrary Capital, a soon-to-be San Francisco-based operation led by Eric Tarczynski, is raising $35 million to invest between $50,000 and $200,000 in students and recent college dropouts. The firm, which operates a summer accelerator program for its portfolio companies, closed on $2.2 million for its debut, proof-of-concept fund in 2018. Contrary Capital celebrating its Demo Day event last year Last year, Contrary kicked off its summer accelerator, tapping 10 university-started …

Erectile pharmacy app Ro launches telehealth service for women

Six months ago, Roman, the cloud pharmacy for erectile dysfunction, dropped the “man” to become “Ro.” At the same time, the company raised a monstrous Series A funding round of $88 million and unveiled Zero, a product meant to help people quit smoking, a root cause of ED. Now, Ro is addressing a different demographic. Today, it announces Rory, a line of products for menopausal women. In total, Rory offers six products treating four conditions, with prices starting at $13 per month. Prescription medication and supplements for hot flashes, over-the-counter treatments for insomnia, prescription vaginal estrogen cream and an all-natural water-based lubricant for vaginal dryness and Latisse, which helps grow eyelashes, are available for purchase and direct-to-consumer delivery. All of …